<code id='B22EFA6C98'></code><style id='B22EFA6C98'></style>
    • <acronym id='B22EFA6C98'></acronym>
      <center id='B22EFA6C98'><center id='B22EFA6C98'><tfoot id='B22EFA6C98'></tfoot></center><abbr id='B22EFA6C98'><dir id='B22EFA6C98'><tfoot id='B22EFA6C98'></tfoot><noframes id='B22EFA6C98'>

    • <optgroup id='B22EFA6C98'><strike id='B22EFA6C98'><sup id='B22EFA6C98'></sup></strike><code id='B22EFA6C98'></code></optgroup>
        1. <b id='B22EFA6C98'><label id='B22EFA6C98'><select id='B22EFA6C98'><dt id='B22EFA6C98'><span id='B22EFA6C98'></span></dt></select></label></b><u id='B22EFA6C98'></u>
          <i id='B22EFA6C98'><strike id='B22EFA6C98'><tt id='B22EFA6C98'><pre id='B22EFA6C98'></pre></tt></strike></i>

          Home / Wikipedia / comprehensive

          comprehensive


          comprehensive

          author:fashion    Page View:1879
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In